Months after the FDA reported multiple violations at an Intas Pharmaceuticals plant in India and blocked imports, the agency shared more details Aug. 1, including a report of an analyst pouring acid in a trash can filled with drug quality documents.
Read the full post on Becker's Hospital Review - Healthcare News
